Daniel N. Swisher JR - 10 Jul 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr.
Issuer symbol
CORT
Transactions as of
10 Jul 2025
Transactions value $
-$125,400
Form type
4
Filing time
14 Jul 2025, 16:36:16 UTC
Previous filing
12 Jun 2025
Next filing
12 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Swisher Daniel N JR Director C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr. 14 Jul 2025 0001323113

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $31K +2.2K $14.08 2.2K 10 Jul 2025 Direct
transaction CORT Common Stock Sale -$156K -2.2K -100% $71.08 0 10 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -2.2K -22.22% $0.00 7.7K 10 Jul 2025 Common Stock 2.2K $14.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.